Processing

Please wait...

Settings

Settings

1. WO1991000737 - TREATMENT OF OBESITY AND ESSENTIAL HYPERTENSION AND RELATED DISORDERS

Publication Number WO/1991/000737
Publication Date 24.01.1991
International Application No. PCT/US1990/003795
International Filing Date 10.07.1990
IPC
A61K 38/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
A61K 38/22 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
C07K 16/26 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
26against hormones
CPC
A61K 38/22
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
A61K 38/225
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
225Calcitonin gene related peptide
C07K 16/26
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
26against hormones ; ; against hormone releasing or inhibiting factors
Applicants
  • AMYLIN CORPORATION [US/US]; 11035 Roselle Street, Suite C San Diego, CA 92121, US
Inventors
  • COOPER, Garth, J., S.; US
  • LEIGHTHON, Brendan; GB
Agents
  • DUFT, Bradford, J. ; Lyon & Lyon 611 West Sixth Street, 34th Floor Los Angeles, CA 90017, US
Priority Data
377,65210.07.1989US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TREATMENT OF OBESITY AND ESSENTIAL HYPERTENSION AND RELATED DISORDERS
(FR) TRAITEMENT DE L'OBESITE ET DE L'HYPERTENSION ESSENTIELLE AINSI QUE DES TROUBLES ASSOCIES
Abstract
(EN)
The present invention is directed to the administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis in mammals.
(FR)
L'invention se rapporte à l'administration d'antagonistes et de bloquants d'amyline ou de CGRP ou des deux, en vue du traitement de l'obésité et de l'hypertension essentielle ainsi que des troubles lipidiques associés et de l'athérosclérose.
Also published as
FI911179
NO19910901
Latest bibliographic data on file with the International Bureau